{"id":41,"date":"2021-02-17T17:24:34","date_gmt":"2021-02-17T16:24:34","guid":{"rendered":"http:\/\/sitnopharma.sk\/?page_id=41"},"modified":"2026-01-14T20:38:10","modified_gmt":"2026-01-14T19:38:10","slug":"historia","status":"publish","type":"page","link":"https:\/\/sitnopharma.sk\/en\/historia\/","title":{"rendered":"History"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

SITNO PHARMA<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

HISTORY<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\n
\n
<\/div> \n
2012<\/div><\/div>
<\/i><\/div>
<\/div>
Establishment of SITNO PHARMA Ltd.<\/div><\/div><\/div>
2016<\/div><\/div>
<\/i><\/div>
<\/div>
Co-founder of the Biotox cluster since 2020 InterBioTox<\/div><\/div><\/div>
2012<\/div><\/div>
<\/i><\/div>
<\/div>
Capital entry into the company TAU-CHEM Ltd.<\/div><\/div><\/div>
2017<\/div><\/div>
<\/i><\/div>
<\/div>
Project Aseptic production of liquid dosage forms<\/div><\/div><\/div>
2018<\/div><\/div>
<\/i><\/div>
<\/div>
Sale of TAU-CHEM, Ltd.<\/div><\/div><\/div>
2019<\/div><\/div>
<\/i><\/div>
<\/div>
Obtaining a certificate for research activities from the Ministry of Education, Youth and Sports of the Slovak Republic<\/div><\/div><\/div>
2019<\/div><\/div>
<\/i><\/div>
<\/div>
Joining the interest association of legal entities Omics4Health<\/div><\/div><\/div>
2019<\/div><\/div>
<\/i><\/div>
<\/div>
Projekt v r\u00e1mci programu Dlhodob\u00e9ho strategick\u00e9ho v\u00fdskumu v dom\u00e9ne Zdravie obyvate\u013estva a zdravotn\u00edcke technol\u00f3gie (31.3.2019). <\/div>
K\u00f3d \u017eiadosti: NFP 313010W003.<\/div>
Project partners:<\/div>
Faculty of Medicine, Comenius University in Bratislava<\/div>
Jes\u00e9nio Faculty of Medicine, Comenius University, Martin<\/div>
Fakulta chemickej a potravin\u00e1rskej technol\u00f3gie Slovenskej technickej univerzity Bratislava,<\/div>
Hameln, rds.<\/div><\/div><\/div><\/div><\/div>
2019<\/div><\/div>
<\/i><\/div>
<\/div>
Projekt podan\u00fd v r\u00e1mci programu Strategick\u00e9 priemyseln\u00e9 v\u00fdskumno-v\u00fdvojov\u00e9 centr\u00e1 v dom\u00e9ne Zdravie obyvate\u013estva a zdravotn\u00edcke technol\u00f3gie (29.9.2019). \u201eVybudovanie v\u00fdskumno-v\u00fdvojov\u00e9ho centra pre v\u00fdrobu nov\u00fdch aseptick\u00fdch liekov\u201c.<\/div>
Application code: NFP313010Y329.<\/div>
Partner:<\/div>
Institute of Chemistry of the Slovak Academy of Sciences. Location Saneca, a.s. Hlohovec.<\/div><\/div><\/div><\/div>
2020<\/div><\/div>
<\/i><\/div>
<\/div>
Project Covid 19<\/div><\/div><\/div>
2020<\/div><\/div>
<\/i><\/div>
<\/div>
Arranging the acquisition of a GMP (Good Manufacturing Practice) permit valid within the European Union for contractual partners:<\/div>
Zdorovje, Ukraine, Farmex, Ukraine<\/div><\/div><\/div><\/div><\/div>
2020<\/div><\/div>
<\/i><\/div>
<\/div>
Z\u00edskanie licencii a uvedenie vybran\u00fdch liekov na trhy \u010cR a SR<\/div><\/div><\/div>
2020<\/div><\/div>
<\/i><\/div>
<\/div>
Poskytnutie licencie firme Pharma Revolta, ktor\u00e1 bude vystupova\u0165 ako \u201eDr\u017eite\u013e rozhodnutia o registr\u00e1cii\u201c MAH (Marketing Authorisation Holder) a zabezpe\u010dova\u0165 v\u0161etky \u010dinnosti spojen\u00e9 s distrib\u00faciou liekov a liekov\u00fdch pr\u00edpravkov na trhu SR a \u010cR<\/div><\/div><\/div>
30.6.2023<\/div><\/div>
<\/i><\/div>
<\/div>
Ukon\u010denie projektu financovan\u00e9ho z Eur\u00f3pskych \u0161truktur\u00e1lnych a investi\u010dn\u00fdch fondov (E\u0160IF). \u201eV\u00fdvoj produktov modifik\u00e1ciou pr\u00edrodn\u00fdch l\u00e1tok a \u0161t\u00fadium ich multimod\u00e1lnych \u00fa\u010dinkov na ochorenie COVID-19\u201c. ITMS: 13011ATT2 <\/div><\/div><\/div>
30.6.2023<\/div><\/div>
<\/i><\/div>
<\/div>
Ukon\u010denie projektu medzin\u00e1rodnej spolupr\u00e1ce v dom\u00e9nov\u00fdch oblastiach \u0161pecializ\u00e1cie RIS3 SK, \u201e\u0160t\u00fadium \u0161truktur\u00e1lnych zmien komplexn\u00fdch glykokonjug\u00e1tov v procese dedi\u010dn\u00fdch metabolick\u00fdch a civiliza\u010dn\u00fdch chor\u00f4b\u201c, ITMS: 313021Y920<\/div><\/div><\/div>
30.6.2023<\/div><\/div>
<\/i><\/div>
<\/div>
Ing. Simona Kro\u0161l\u00e1kov\u00e1, new employee of Sitno Pharma.<\/div><\/div><\/div>
4.10.2023<\/div><\/div>
<\/i><\/div>
<\/div>
Sitno Pharma je partnerom projektu z Pl\u00e1nu obnovy a odolnosti: Potenci\u00e1l prirodzene sa vyskytuj\u00facich l\u00e1tok a ich deriv\u00e1tov v prevencii a lie\u010dbe civiliza\u010dn\u00fdch ochoren\u00ed a ochrane zdravia. Skr\u00e1ten\u00fd n\u00e1zov projektu: PreHealth<\/div><\/div><\/div>
4.11.2023<\/div><\/div>
<\/i><\/div>
<\/div>
zriadenie spolo\u010dn\u00e9ho pracoviska Chemick\u00e9ho \u00fastavu SAV v.v.i. a Sitno Pharma na v\u00fdskum extrakcie a lyofiliz\u00e1cie pr\u00edrodn\u00fdch l\u00e1tok.<\/div><\/div><\/div>
3.7.2024<\/div><\/div>
<\/i><\/div>
<\/div>
Ozn\u00e1menie z V\u00fdskumnej agent\u00fary o schv\u00e1len\u00ed z\u00e1vere\u010dnej monitorovacej spr\u00e1vy projektu \u201eV\u00fdvoj produktov modifik\u00e1ciou pr\u00edrodn\u00fdch l\u00e1tok a \u0161t\u00fadium ich multimod\u00e1lnych \u00fa\u010dinkov na ochorenie COVID-19\u201c a za\u010diatku plynutia monitorovacieho obdobia<\/div><\/div><\/div>
8.1 2025<\/div><\/div>
<\/i><\/div>
<\/div>
Certifika\u010dn\u00fd audit 1. stup\u0148a pod\u013ea normy ISO 9001\/2015 uskuto\u010dnen\u00fd ASTRAIA Certification s.r.o., <\/div><\/div><\/div>
14.1.2025<\/div><\/div>
<\/i><\/div>
<\/div>
Udelenie certifik\u00e1tu syst\u00e9mu mana\u017e\u00e9rstva kvality pod\u013ea normy ISO 9001:2015 v rozsahu t\u00fdchto \u010dinnost\u00ed: organiz\u00e1cia, koordin\u00e1cia a vedenie projektov zameran\u00fdch na v\u00fdskum, v\u00fdvoj a testovanie pr\u00edrodn\u00fdch extraktov, \u00fa\u010dinn\u00fdch a pomocn\u00fdch l\u00e1tok pre farmaceutick\u00fd priemysel ako aj pr\u00edrodn\u00fdch zl\u00fa\u010den\u00edn, zmes\u00ed a deriv\u00e1tov pre chemick\u00fd a potravin\u00e1rsky priemysel za \u00fa\u010delom ich registr\u00e1cie a uvedenia na trh.<\/div><\/div><\/div>
17.2.2025<\/div><\/div>
<\/i><\/div>
<\/div>
Obnovenie \u201eOsved\u010denia o sp\u00f4sobilosti vykon\u00e1va\u0165 v\u00fdskum a v\u00fdvoj\u201c s platnos\u0165ou do roku 2031.<\/div><\/div><\/div>
7.5.2025<\/div><\/div>
<\/i><\/div>
<\/div>
Projekt \u201eDlhodob\u00fd strategick\u00fd v\u00fdskum zvy\u0161ovania kvality a bezpe\u010dnosti koncentr\u00e1tov pr\u00edrodn\u00fdch l\u00e1tok\u201c podan\u00fd v programe \u201eProgram Slovensko\u201c. \u017diadate\u013e Chemick\u00fd \u00fastav SAV, v.v.i. Partneri: Calendula, a.s., Centrum biovied SAV, v.v.i., Centrum experiment\u00e1lnej medic\u00edny SAV, v.v.i., N\u00e1rodn\u00e9 po\u013enohospod\u00e1rske a potravin\u00e1rske centrum, Sitno Pharma s.r.o., Fakulta chemickej a potravin\u00e1rskej technol\u00f3gie STU<\/div><\/div><\/div>
5.11.2025<\/div><\/div>
<\/i><\/div>
<\/div>
Mgr. Patrik Ku\u0161n\u00edr, riadite\u013e toxikol\u00f3gie, bol vymenovan\u00fd za konate\u013ea spolo\u010dnosti SITNO PHARMA s.r.o.<\/div><\/div><\/div>
18. 12.2025<\/div><\/div>
<\/i><\/div>
<\/div>
\u00daspe\u0161ne absolvovan\u00fd doh\u013eadov\u00fd audit SITNO PHARMA s.r.o. aud\u00edtorskou spolo\u010dnos\u0165ou Astraia Certification s.r.o. na syst\u00e9m mana\u017e\u00e9rstva kvality v\u00a0s\u00falade s\u00a0po\u017eiadavkami krit\u00e9ri\u00ed uveden\u00fdch v ISO 9001 :2015<\/div><\/div><\/div><\/div>\n
<\/div>\n <\/div>